tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

JOINN Laboratories Details 2026 Caps for Connected R&D and BioAI Service Deals

Story Highlights
  • JOINN set a RMB47 million 2026 cap for Staidson R&D work, reflecting expected projects, costs and capacity.
  • The company set a RMB16.5 million 2026 cap for BioAI digital and automation services based on projected demand and costs.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
JOINN Laboratories Details 2026 Caps for Connected R&D and BioAI Service Deals

Claim 50% Off TipRanks Premium

JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) has provided an announcement.

JOINN Laboratories (China) Co., Ltd. has issued a supplemental announcement detailing how it set the 2026 annual cap of RMB47 million for continuing connected transactions with Staidson under their research and development service framework agreement. The cap reflects anticipated non-clinical and clinical projects in 2026, historical transaction levels, labor and equipment costs, and JOINN’s capacity, with expected payments including both new 2026 projects and ongoing work from previous years; the size of these connected transactions triggers disclosure and annual review requirements under Hong Kong Listing Rules but does not require independent shareholders’ approval. The company also clarified the basis for a RMB16.5 million annual cap for 2026 services to be procured from BioAI, covering software development, automation, system integration, and digital/intelligent operations technical services, which is informed by JOINN’s expected project demand and BioAI’s service cost structure, underscoring increasing investment in digitalization alongside continued collaboration with related parties.

The most recent analyst rating on (HK:6127) stock is a Hold with a HK$28.00 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.

More about JOINN Laboratories (China) Co., Ltd. Class H

JOINN Laboratories (China) Co., Ltd. is a China-based contract research organization specializing in non-clinical and clinical drug research and development services. The company provides laboratory-based R&D, testing and related technical services to pharmaceutical and biotechnology clients, with a focus on supporting drug development pipelines and associated digital and intelligent production needs.

Average Trading Volume: 5,041,399

Technical Sentiment Signal: Buy

Current Market Cap: HK$32.71B

For an in-depth examination of 6127 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1